MY140986A - S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same - Google Patents

S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Info

Publication number
MY140986A
MY140986A MYPI20081014A MYPI20081014A MY140986A MY 140986 A MY140986 A MY 140986A MY PI20081014 A MYPI20081014 A MY PI20081014A MY PI20081014 A MYPI20081014 A MY PI20081014A MY 140986 A MY140986 A MY 140986A
Authority
MY
Malaysia
Prior art keywords
same
hydrate
pharmaceutical composition
omeprazole strontium
preparing
Prior art date
Application number
MYPI20081014A
Inventor
Ha Tae Hee
Oh Hee Sook
Kim Won Jeoung
Park Chang Hee
Kim Eun Young
Kim Young Hoon
Suh Kwee Hyun
Lee Gwan Sun
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of MY140986A publication Critical patent/MY140986A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

ABSTRACT THIS INVENTION PROVIDES S-OMEPRAZOLE STRONTIUM OR A HYDRATE THEREOF FOR THE PREVENTION OR TREATMENT OF A GASTRIC ACID-RELATED DISEASE, WHICH HAS HIGH OPTICAL PURITY, THEREMOSTABILITY, SOLUBILITY AND NONHYGROSCOPICITY, A METHOD FOR PREPARING SAME, AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME.
MYPI20081014A 2005-10-26 2008-04-07 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same MY140986A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20050101059 2005-10-26
KR2006000760 2006-03-06

Publications (1)

Publication Number Publication Date
MY140986A true MY140986A (en) 2010-02-12

Family

ID=37967988

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20081014A MY140986A (en) 2005-10-26 2008-04-07 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Country Status (8)

Country Link
JP (1) JP5017274B2 (en)
AU (1) AU2006306906B2 (en)
CA (1) CA2626085C (en)
IL (1) IL190709A (en)
MY (1) MY140986A (en)
NO (1) NO20082358L (en)
RU (1) RU2372345C1 (en)
WO (1) WO2007049914A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (en) * 1983-03-04 1983-03-04 Haessle Ab NOVEL COMPOUNDS
SE510650C2 (en) * 1997-05-30 1999-06-14 Astra Ab New association
WO2004099182A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
ATE386522T1 (en) * 2003-07-23 2008-03-15 Nycomed Gmbh ALKALINE SALTS OF PROTON PUMP INHIBITORS
RU2007145207A (en) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) ESOMEPRAZOL STRONGTED SALT, METHOD FOR PRODUCING IT AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
JP5017274B2 (en) 2012-09-05
IL190709A0 (en) 2008-11-03
RU2372345C1 (en) 2009-11-10
CA2626085A1 (en) 2007-05-03
CA2626085C (en) 2011-12-06
AU2006306906B2 (en) 2010-02-04
WO2007049914A1 (en) 2007-05-03
IL190709A (en) 2012-03-29
NO20082358L (en) 2008-07-25
JP2009513625A (en) 2009-04-02
AU2006306906A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
HK1104035A1 (en) Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same
WO2007111864A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2007136577A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
TN2009000111A1 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2007084221A3 (en) Methods and apparatus for identifying subject matter in view data
TW200833666A (en) Ansamycin formulations and methods of use thereof
UA96126C2 (en) Compound for inhibition of rhokinase activity, pharmaceutical composition comprising such a compound and method of inhibiting the activity of a rhokinase
WO2007087548A3 (en) Chemical compounds
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
MX2012007375A (en) 3-keto-n-propargyl-1-aminoindan.
TW200745044A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
WO2006057922A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2007120575A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2007109799A3 (en) Polymorphs of eszopiclone malate
WO2008034142A3 (en) Synthesis, methods of using, and compositions of cycloalkylmethylamines
IL193252A0 (en) N-hydroxyacrylamide compounds
MX2008015775A (en) Compounds and compositions for treatment of cancer.
WO2007075749A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride
NO20080037L (en) Combination of Pyrimidylaminobenzamide Compounds and Imatinib for the Treatment or Prevention of Proliferative Diseases
TW200638932A (en) CCI-779 polymorph and use thereof
WO2007138468A3 (en) Processes for the preparation of lansoprazole
EP1881974A4 (en) Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
WO2005077385A3 (en) Methods for treating resistant or refractory tumors